Association between Helicobacter pylori infection and newly diagnosed childhood immune thrombocytopenia.
- Author:
Yan-Yang CHENG
1
;
Hao XIONG
;
Zhi-Liang XU
;
Jian-Xin LI
;
Hui LI
;
Wei CAI
;
Jie HAN
;
Jiao-Jiao LI
;
Lin GUO
Author Information
- Publication Type:Journal Article
- MeSH: Adolescent; Age Factors; Child; Child, Preschool; Female; Helicobacter Infections; complications; epidemiology; Helicobacter pylori; Humans; Incidence; Infant; Male; Purpura, Thrombocytopenic, Idiopathic; etiology
- From: Chinese Journal of Contemporary Pediatrics 2015;17(1):22-25
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo study the role of Helicobacter pylori (H. pylori) infection in newly diagnosed childhood immune thrombocytopenia (ITP).
METHODSA total of 495 children with newly diagnosed ITP who were hospitalized for the first time between January 2011 and December 2013 were included as the case group. A total of 123 children with common respiratory tract infection (not ITP or other diseases of blood system) were randomly selected as the control group. All patients were divided into four groups by age: <1 year group, 1-3 years group, 3-7 years group, and 7-14 years group. The incidence of H. pylori infection in all age groups and the clinical outcomes of ITP children with or without H. pylori infection were retrospectively analyzed.
RESULTSThe incidence rate of H. pylori infection in the case group increased with increasing age. There was no significant difference in the incidence rate of H. pylori infection between the case and the control groups among subjects of the same age (P>0.05). All the ITP patients were not given anti-H. pylori treatment and only received the treatment (glucocorticoid and/or immunoglobulin) for ITP, and their remission rate declined with increasing age. There was no significant difference in the remission rate between the ITP children with H. pylori infection and those without H. pylori infection in the same age group (P>0.05).
CONCLUSIONSH. pylori infection may not be a major cause of ITP in children, and the clinical outcomes of children with acute ITP are not affected by receiving anti-H. pylori treatment or not.